p.kjaer
Submits third-party assay reports on material purchased directly. Based in Utrecht.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
9
n=9
Annotations
0
n=0
Median purity submitted
99.02%
n=9
Suppliers covered
8
n=9
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-041333 | Semaglutide | WWB | WWB-2606-N3192 | Janoshik | 2026-Q3 | 98.80 | 4.51 | 90.6 | Laboratory-retained | 1 | MARGINAL |
| AX-2025-021210 | Gonadorelin | BCH | BCH-2510-F6239 | Janoshik | 2025-Q4 | 99.02 | 5.73 | 104.5 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018873 | TB-500 | QSC | QSC-2505-B8934 | Medutest | 2025-Q3 | 99.66 | 4.84 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019471 | Retatrutide | Homopeptide | HOMO-2508-U9007 | Janoshik | 2025-Q3 | 99.17 | 6.35 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2024-005510 | Semaglutide | BCH | BCH-2402-K7631 | Medutest | 2024-Q3 | 97.94 | 2.60 | 89.2 | Buyer-sourced | 3 | MARGINAL |
| AX-2024-005196 | Retatrutide | SSA | SSA-2405-G6398 | Janoshik | 2024-Q3 | 97.27 | 7.04 | — | Buyer-sourced | 2 | MARGINAL |
| AX-2024-005053 | PT-141 (Bremelanotide) | MKM | MKM-2404-E2618 | Janoshik | 2024-Q3 | 99.93 | 4.21 | 105.1 | Supplier-supplied | 0 | PASS |
| AX-2024-004898 | BPC-157 | ERP | ERP-2402-U6523 | Janoshik | 2024-Q3 | 98.92 | 4.18 | 96.4 | Supplier-supplied | 2 | MARGINAL |
| AX-2024-004290 | Melanotan II | QYB | QYB-2402-P5428 | Janoshik | 2024-Q2 | 99.69 | 5.51 | 97.6 | Supplier-supplied | 1 | MARGINAL |